Celebrate World Pharmacist Day 2025 at The Royal Marsden!
The Royal Marsden invite BOPA members and colleagues to help us celebrate World Pharmacist Day on 25th September 2025 at an evening meeting. The meeting will include presentations from Dame…
The Royal Marsden invite BOPA members and colleagues to help us celebrate World Pharmacist Day on 25th September 2025 at an evening meeting. The meeting will include presentations from Dame…
📢 New Joint Statement from International Society of Oncology Pharmacy Practitioners (ISOPP) and Union for International Cancer Control (UICC) Substandard and falsified (SF) cancer medicines are jeopardising treatment outcomes and…
BOPA Members, As part of our ongoing and increased collaborations with the British Society of Haematology (BSH) we would like to circulate the BSH Membership Survey 2025. BSH are seeking…
We’re excited to announce the next Pharmacists’ Essential Guide to Haematology course, hosted by the UCLH Cancer Academy. This two-day course is designed specifically for pharmacists starting their haem-oncology journey,…
The UK Pharmacy Professional Leadership Advisory Board (UKPPLAB) is leading development of a collaborative, inclusive, and effective model of pharmacy professional leadership (PPL) across the UK. Eight UK PPL organisations have…
Titilayo Alagbe, Co-Chair of The BOPA Independent Sector Oncology Pharmacy (BISOP) Group has joined the UK Black Pharmacist Association (UKBPA) as a board member. The Mission and Vision is to…
BOPA’S Vice Chair Professor Shereen Nabhani-Gebara had an interview with Hospital Pharmacy Europe on upskilling and supporting the oncology pharmacy workforce! Access the article HERE: Professor Shereen Nabhani-Gebara on upskilling…
Hana (@Pharmadrama attends the ITC course) – Access the post here Instagram I went to the @bopacommittee “Introduction to Cancer” 2-day workshop and here’s a video of what happened 😊…
BOPA is an Ex-Officio Member (Specialist Pharmacy Group) of the UKPPL Board with our Chair, Joseph Williams, representing BOPA members and all Cancer Pharmacy Professionals. Through the Board’s work, closer…
BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…
The Immuno-Oncology Clinical Network (IOCN) and the British Cardio-Oncology Society (BCOS) are proud to announce the publication of their first joint consensus statement: “Baseline Cardiac Assessment in Individuals Receiving Immune Checkpoint Inhibitors:…
Update from the UK Pharmacy Professional Leadership Advisory Board The UK Pharmacy Professional Leadership Advisory Board met for the fourth time on 10 December 2024. Through the Board’s work, closer…